Versant Venture Management, LLC
- SEC CIK
- 0001560009
- Latest filing
- Aug 12, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 5, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 8
- +1 vs. Q4 2025
- Portfolio value
- $141.4M
- −$9.65M (−6.4%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GLUEMonte Rosa Therapeutics, Inc. | COM | 3,180,780 | $52.3M | 37.0% | −1,201,907−27.4% | Reduced | History |
| IPSCCentury Therapeutics, Inc. | COM | 12,166,109 | $27.5M | 19.4% | +12,166,109 | New | History |
| LENZLENZ Therapeutics, Inc. | COM | 2,656,888 | $24.3M | 17.2% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,525,820 | $21.4M | 15.2% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 542,628 | $7.09M | 5.0% | 00.0% | Unchanged | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 148,831 | $7.08M | 5.0% | 00.0% | Unchanged | History |
| SKYESkye Bioscience, Inc. | COM NEW | 2,007,704 | $1.23M | 0.9% | 00.0% | Unchanged | History |
| TPSTTempest Therapeutics, Inc. | COM | 269,772 | $442.4K | 0.3% | 00.0% | Unchanged | History |